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Parasite infections are largely dependent on interactions between pathogen and different
host cell populations to guarantee a successful infectious process. This is particularly
true for obligatory intracellular parasites as Plasmodium, Toxoplasma, and Leishmania,
to name a few. Adhesion to and entry into the cell are essential steps requiring specific
parasite and host cell molecules. The large amount of possible involved molecules poses
additional difficulties for their identification by the classical biochemical approaches. In
this respect, the search for alternative techniques should be pursued. Among them two
powerful methodologies can be employed, both relying upon the construction of highly
diverse combinatorial libraries of peptides or oligonucleotides that randomly bind with
high affinity to targets on the cell surface and are selectively displaced by putative ligands.
These are, respectively, the peptide-based phage display and the oligonucleotide-based
aptamer techniques. The phage display technique has been extensively employed for
the identification of novel ligands in vitro and in vivo in different areas such as cancer,
vaccine development, and epitope mapping. Particularly, phage display has been employed
in the investigation of pathogen–host interactions. Although this methodology has been
used for some parasites with encouraging results, in trypanosomatids its use is, as yet,
scanty. RNA and DNA aptamers, developed by the SELEX process (Systematic Evolution
of Ligands by Exponential Enrichment), were described over two decades ago and since
then contributed to a large number of structured nucleic acids for diagnostic or therapeutic
purposes or for the understanding of the cell biology. Similarly to the phage display
technique scarce use of the SELEX process has been used in the probing of parasite–host
interaction. In this review, an overall survey on the use of both phage display and aptamer
technologies in different pathogenic organisms will be discussed. Using these techniques,
recent results on the interaction of Trypanosoma cruzi with the host will be highlighted
focusing on members of the 85 kDa protein family, a subset of the gp85/TS superfamily.
Keywords: combinatorial methods for diagnosis and therapy, phage display, aptamers, SELEX, Kinetoplastidae,
apicomplexa
INTRODUCTION
Phage display technology and RNA and DNA aptamers, devel-
oped by the SELEX process (Systematic Evolution of Ligands by
Exponential enrichment), were described over two decades ago
and since then contributed to a large number of small peptides or
structured nucleic acids for diagnostic or therapeutic purposes or
for the understanding of the cell biology (Figure 1). Comparison
of normal cells with cancer or infected cells and vascular endothe-
lium of organs are the most visible examples. The small peptides
or nucleic acids of interest can be modified to increase their half-
life in the organism or to be conjugated to other molecules, such
as fluorescence probes, nanoparticles, or immobilized matrices,
increasing their potential use.
PHAGE DISPLAY
The use of filamentous bacteriophages (virus that infect bacte-
ria) to express and display foreign protein fragments or peptides
started in the mid-1980s when a portion of the gene encoding
the EcoRI endonuclease was fused to the gene coding for the pIII
protein coat from a M13 virus (Smith, 1985). The result of this
original experiment was the production of hybrid filamentous
bacteriophages, or fusion phages, expressing and displaying the
product of the fusion gene into the minor capsid protein pIII on
the surface of the phage particle (Smith, 1985). This approach
represented a landmark in the field of molecular genetics, because
firstly foreign DNA was directly linked to the replicating phage
genome and secondly, the phage operated like an “expression
vector” with the foreign DNA being expressed as a “protein” asso-
ciated to the phage protein coat (Smith and Scott, 1993; Smith
and Petrenko, 1997).
Most phage-display work has used filamentous phage strains
(M13 and its close relatives fd and f1) as vectors. Filamentous bac-
teriophage consists of a circular single-stranded DNA (ssDNA)
genome covered by a few thousand copies of the major coat
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FIGURE 1 | Parasite targetting by combinatorial techniques. (A) Phage
display. A phage library displaying potential ligand proteins on their surface
is exposed to an immobilized target (step 1). After washing away unbound
phages (step 2), binders are eluted by Escherichia coli infection and plated
on LB-agar (step 3). Clones are then amplified producing a phage mixture
that is enriched with relevant (i.e., binding) phage (step 4). The repeated
cycling of these steps is referred as “panning”. At the end of 3–4 rounds
of panning the enriched phage population is recovered by infection of a
suitable bacterial host and sequenced to identify the interacting peptides or
protein fragments. (B) SELEX. It is based on a stretch of single-stranded
nucleic acid, which can be RNA or single-stranded DNA (ss-DNA). These
are chemically synthesized to have a random stretch usually from 8 to 40
nucleotides, flanked by constant sequences. In the case of RNA SELEX,
the synthetic DNA template is transcribed into a pool of 1013–1014 different
RNA molecules (step 1). The pool is incubated with the desired targets
and due to the sample diversity some of the aptamers will bind to their
targets (step 2). After washing out unbound RNAs (step 3) the different
RNA pools are displaced by incubation with ligands of interest (step 4).
By reverse transcription (step 5) and PCR amplification (step 6) selected
double-stranded DNAs are reconstructed. The same cycle is repeated over
8–12 times until purified sequences specific for a given ligand are selected.
The DNAs are cloned and sequenced. This iterative method follows the
same logic when single-stranded DNA sequences are used as aptamers
instead of RNA (Ulrich and Wrenger, 2009).
protein pVIII (∼2700 copies in wild type phage) with each end
capped by five copies of two different sets of proteins: pIII and pVI
at the end that binds to bacteria and inject the DNA into the host
cell; pVII and pIX at the other end (Marvin, 1998). Each of the five
capsidic proteins has been used to display foreign polypeptides
on the surface of the M13 bacteriophage but the minor protein
pIII is most commonly used (Greenwood et al., 1991; Smith and
Petrenko, 1997). Despite the ease manipulation and extraordinary
stability of the phage particle, the display of foreign proteins is
not without difficulties and imposes that polypeptides have a lim-
ited size, sequence, and folding characteristics, as large molecules
may compromise the structure and function of the protein coat
(Sidhu, 2000). This restraint has led researchers to cast about
for new protein display scaffolds resulting in the development of
phagemid display systems (Qi et al., 2012). Phagemid was devel-
oped as a hybrid of the filamentous phage M13 and a plasmid to
produce a vector that can grow as a plasmid, and also be packaged
as single stranded DNA in viral particles. When introduced into
a bacterial host together with a “helper-phage,” phagemid sys-
tems allow the display of both fusion and wild type coat proteins
attenuating possible defects on phage function (Sidhu, 2000;
Qi et al., 2012).
In recent years display of heterologous proteins on the sur-
face of microorganisms is not restricted to the filamentous phage
(Smith, 1985). Alternative display systems that use bacterio-
phage λ (Sternberg and Hoess, 1995), lytic phages like T4 and
T7 (Efimov et al., 1995; Ren et al., 1996), eukaryotic viruses such
as baculovirus (for a review see Makela et al., 2010), bacteria
(Georgiou et al., 1997), and yeast are also used, each one hav-
ing advantages and disadvantages with respect to each particular
application.
The benefits behind the display systems have also encouraged
the development of a new generation of selection technolo-
gies. Cell-free systems like ribosome (He and Taussig, 2002),
mRNA (Takahashi et al., 2003) and DNA display technologies
(Yonezawa et al., 2004) are proven to be more advantageous than
phage display, as larger libraries (up to 1014) can be constructed.
While in the ribosome display, individual nascent proteins are
coupled to their corresponding mRNA through the formation
of stable ternary protein–ribosome–mRNA (PRM) complexes,
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in the other two systems protein fragments and peptides are
covalently coupled to a DNA/RNA template (He and Taussig,
2002; Takahashi et al., 2003; Bertschinger and Neri, 2004).
These technologies are becoming more commonplace, but the
phage display platform remains the leading technology (Sidhu,
2000).
Phage display libraries are heterogeneous mixtures of fusion
phages, each one carrying a different foreign DNA insert and dis-
playing a different protein on filamentous phage surface (Cwirla
et al., 1990; Devlin et al., 1990; Scott and Smith, 1990; Smith and
Petrenko, 1997). Such libraries containing billions of phage clones
(some libraries are as high as 1012 diverse) are extensively used to
screen and select for peptides that bind with high-affinity to tar-
get molecules. The selection procedure known as “panning” or
“biopanning” (depending whether selection is performed in vitro
or in vivo, respectively) is simple and involves four major steps
(Figure 1) (Parmley and Smith, 1988). After 3–5 rounds of selec-
tion against the desired target, individual clones are isolated and
the primary structure of the binding peptides is deduced by
nucleotide sequencing. Peptide sequences obtained in this man-
ner may then be used in alignment search for known proteins
(Koivunen et al., 1999).
APPLICATIONS OF PHAGE DISPLAY
One of the earliest applications of phage display technology was to
study antigen–antibody binding for the identification of epitopes
and mimotopes (small peptides that mimic linear, discontinuous,
and even non-peptide epitopes) (Germaschewski and Murray,
1995). However, it was later shown that larger molecules like anti-
body fragments (scFV, Fab fragment, VHH domains) could be
successfully displayed on phage (McCafferty et al., 1990; Benhar,
2001; Bradbury and Marks, 2004; Petrenko, 2008). The develop-
ment of phages that display antibodies led to the emergence of
a new molecular recognition interface to study protein–protein
interactions, structure-function relationships, and protein fold-
ing and stability (Clackson et al., 1991; Vaughan et al., 1996). As
a result, phage displayed cDNA libraries advanced significantly
with a plethora of ligands fused to phage particles such as gly-
coproteins (Celik et al., 2010), enzymes (Soumillion et al., 1994),
protease inhibitors (Markland et al., 1996), cytokines (Gram et al.,
1993; Buchli et al., 1997), secreted as well as cytoplasmic, nuclear
and membrane proteins (Vithayathil et al., 2011) to cite a few
examples.
With the increasing number of phage display collections,
numerous new applications have emerged. Selections from var-
ious libraries have been used to identify peptide agonists and
antagonists for receptors (Sidhu, 2000), determine bind speci-
ficity of domains (Sparks et al., 1996; Linn et al., 1997), map
carbohydrates and protein functional epitopes (Sidhu, 2000;
Fukuda, 2012), select antibodies recognizing post-translational
modifications (Kehoe et al., 2006), identify targets for the inhibi-
tion of tumor-specific angiogenesis (Koivunen et al., 1999; Arap
et al., 2002; Zurita et al., 2003), vaccine development (Lidqvist
et al., 2008), and molecular imaging with the use of fluores-
cently labeled phage (Newton et al., 2006; Petrenko, 2008). More
recently, there is a strong trend for the use of phage display in
medical science with the production of humanized antibodies
and development of new therapeutics. Indeed, a few selected
peptides and proteins are in clinical or preclinical stages of
development and some are reaching the market (Rothe et al.,
2006).
THE USE OF PHAGE DISPLAY IN THE STUDY OF PARASITIC INFECTIONS
Infectious diseases may be caused by various pathogens like bac-
teria, fungi, virus, multi and unicellular parasites. Independently
of the mechanism by which the pathogenic agent elicits infec-
tion, the surface components are key determinants for the
disease progression. Over the years several laboratories have
made great effort to elucidate the mechanisms involved in
the establishment of infectious diseases and not surprisingly
many of them have focused on the discovery of molecules,
from both the pathogen and the host. Considering this, much
of the work on pathogen–host interaction relied on classi-
cal biochemical and cellular biology approaches (purification,
cross-linking, immunoprecipitation, and fractionation) to track
for ligands and receptors. Nevertheless, with the rapid expan-
sion of the phage display platform and the development of
high throughput selections, pathogenic agents and their hosts
are currently being mapped for toxins, ligands and interact-
ing proteins as well for the identification of possible drug
candidates.
STUDIES ON APICOMPLEXA USING PHAGE DISPLAY
Plasmodium
The phylum apicomplexa encompasses a vast array of organ-
isms, some of which are of major importance in veterinary and
medical areas. Members of the genus Plasmodium, Toxoplasma
and Cryptosporidium, for example, are pathogens of humans and
cause, respectively, malaria, toxoplasmosis and cryptosporidio-
sis. The genus Eimeria contains important parasites of livestocks,
especially poultry, causing coccidiosis. All are unicellular eukary-
otes and are obligatory intracellular parasites circulating between
an intermediate and a definitive host. The potential of the phage
display system in the field of parasitology was first demonstrated
in studies on malaria.
Plasmodium protozoa are transmitted to humans by the bite
of female mosquitoes from the Anopheles genus. Infection in
humans begins when the sporozoites, injected with the saliva
of the mosquito vector during blood meal, spreads through the
bloodstream reaching the liver. Once inside the hepatocytes (exo-
erythrocytic cycle), sporozoites divide repeatedly and differentiate
into merozoites, which once released in the bloodstream infect
the red blood cells (RBCs) beginning the intraerythrocytic cycle.
The surface of RBCs is covered by sialoglycoproteins from which
glycophorins are the major constituent being implicated in mero-
zoite invasion (Howard et al., 1982). To identify the molecular
ligands for the glycophorins, a phage display cDNA library from a
P. falciparum strain dependent on sialic acid to invade RBCs was
used in panning assays against purified humanMN-glycophorins
or isolated RBCs. After four panning rounds, sequencing of indi-
vidual positive clones and BLAST searches using the PlasmoDB,
several parasite proteins that specifically bind to glycophorins
and RBCs were identified. Among them were the erythrocyte-
binding antigen (EBA-175) and the erythrocyte-binding ligand-1
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or EBL-1, both belonging to the superfamily of the erythrocyte
binding-like (EBL) proteins (Li et al., 2012). In addition, the
phage cDNA insert bearing the binding site for glycophorin
encoded a 69-amino acid peptide located within a subdomain
(D2) of the Duffy binding-like domain (DBL) of the EBL-1 gene
(Li et al., 2012).
A different strategy to study host–parasite interactions dur-
ing the intraerythrocytic life cycle of Plasmodium was the use of
a peptide phage display library to identify peptides with affinity
for invading merozoites and infected RBCs (iRBCs). Whenmero-
zoites are prone to invade the erythrocytes, they translocate and
expose on their surface a type I integral membrane protein known
as the apical membrane antigen-1 (AMA-1) (Triglia et al., 2000).
This protein undergoes proteolytic cleavage at around the point of
host invasion and this processing is essential for parasite entry as
antibodies that prevent AMA-1 proteolysis inhibit RBC invasion
in vitro (Dutta et al., 2003). Moreover, during the development of
merozoites inside the RBCs, Plasmodium proteins are associated
or inserted into the host plasma membrane dramatically altering
the composition and structure of the erythrocyte membrane. This
event is an important mechanism exploited by Plasmodium to
evade the host immune system since erythrocytes become covered
with variant antigens (antigenic variation) protecting the parasite
from variant-specific antibodies elicited by earlier infections. This
variation is mediated by the differential control of a family of sur-
face molecules termed PfEMP1 and encoded by approximately
60 var genes as described by the genome sequencing of P. falci-
parum (Aley et al., 1984; Gardner et al., 2002). Considering these
data, panning of random peptide phage display libraries against
AMA-1 and the altered surface of infected Plasmodium erythro-
cytes were performed to identify mimotopes for merozoites and
iRBCs. One of the peptides that bound to AMA-1was shown to be
a potent inhibitor of the invasion of P. falciparummerozoites into
human erythrocytes (Li et al., 2002). When the targets were the
iRBCs, one selected peptide (P1) that constituted more than 40%
of the sequenced phage clones bound specifically to the surface
of infected erythrocytes and showed anti-malarial activity (Eda
et al., 2004).
Phage display has also been used to investigate the host
immunological response against the sporozoites in the pre-
erythrocytic cycle. Peptides that represented the circumsporozoite
protein (CSP), the major surface antigen of the sporozoites, were
inserted into the gene of PVIII of filamentous phage and used
to immunize rabbits to test for the antigenicity of CSP epitopes.
These experiments have shown that CSP can generate a protective
antibody response in addition to provide insights into new anti-
genic epitopes for vaccine development against malaria parasites
(Greenwood et al., 1991).
In an effort to control the development of Plasmodium
inside the invertebrate host, a work focused on the study of
Anopheles-malaria parasites interaction was undertaken. Using
a phage display library and successive rounds of biopanning
with female mosquitoes, a single peptide (SM1) was selected
that bound specifically to the luminal side of the midgut epithe-
lium and to the distal lobe of the salivary glands inhibiting
Plasmodium invasion of the two organs (Ghosh et al., 2001,
2002). Examples on the work of malaria research using phage
display technology are listed in Table 1 (Lanzillotti and Coetzer,
2008).
Toxoplasma gondii
Toxoplasma parasites are another good example of apicomplexa
that served as excellent models in studies involving phage dis-
play technology. Infection with T. gondii occurs by the ingestion
of either infectious oocysts through contact with cats (the defini-
tive host) or cat feces or by feeding with meat that contains tissue
cysts. Although opportunistic in healthy humans, toxoplasmo-
sis is a lethal disease when progressing in chronically infected
individual developing immunodeficiency, particularly in AIDS
patients. As a consequence, much of the work on Toxoplasma
and phage display is focused to cover different aspects of the
immunological response against this parasite. To identify antigens
implicated in human B-cell responses, a lambda phage-display
library of T. gondii cDNA fragments was screened with sera of
infected individuals. As a result, recombinant phage clones were
identified carrying B-cell epitopes present in different T. gondii
antigens like SAG1, GRA1, GRA7, GRA8, and MIC5 (Beghetto
et al., 2003). Using a similar strategy, this group screened a panel
of sera of pregnant women infected with T. gondii and identified
an antigenic peptide within the sequence of the dense granule
GRA1 protein (p24) that is immunodominant in Toxoplasma
infections (Beghetto et al., 2001). Altogether, these data demon-
strated the potential of phage-display technology for antigen
discovery and for the study of the human antibody response
on infectious agents. Data in Table 2 summarize the work on
Toxoplasma research using phage display technology.
Cryptosporidium parvum
To date, 20 different species of Cryptosporidium have been
described based on differences on the host species they infect.
Cryptosporidium species are enteric coccidia parasites causing
cryptosporidiosis (an acute, non-bloody, watery-diarrhea) in
mammalian hosts. Table 3 summarizes work on Cryptosporidium
using phage display technology. C. parvum is of particular con-
cern as it infects humans, especially immune compromised indi-
viduals where the disease may become chronic and cause a
life-threatening gastroenteritis with a high mortality. Infection
with C. parvum occurs when ingested oocysts release sporozoites
in the intestines of a suitable host. The sporozoites then attach
to and invade epithelial cells of the gastrointestinal tract where
they undergo intracellular development through asexual as well
as sexual cycles. Even though many proteins, such as GP900,
CP47, TRAP-C1, GP40, and GP15, have been implicated in the
infection, increasing knowledge on the host–parasite interacting
molecules is crucial for designing strategies to combat cryp-
tosporidiosis. This has been investigated by panning a cDNA
library of the sporozoite and oocyst stages of C. parvum expressed
on the surface of T7 phage against intestinal epithelial cells (IECs).
This study has identified a surface 12 kDa protein (CP12) that
localizes especially at the apical region of sporozoites (Yao et al.,
2007). Another work has identified the CP2, a known surface
molecule of sporozoites involved in the invasion process, when
the C. parvum T7 phage display library was screened by using
Caco-2 (human epithelial colorectal adenocarcinoma) cells (Guo
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Table 1 | Summary of phage display applications in malaria research.
Target Library Result References
Mosquito epithelia Random peptides Identification of SM1 peptide that inhibits
salivary gland invasion by Plasmodium
Ghosh et al., 2001, 2002
Ookinete surface Random peptides Identification of enolase and actin on the
surface of ookinetes
Hernandez-Romano et al.,
2011
Parasitized erythrocyte Random peptides Identification of a peptide that binds to
the surface of Plasmodium-infected
erythrocytes. Isolation of an antibody
against a peptide that causes hemolysis
of iRBCs
Eda et al., 2004
Erythrocyte surface
proteins
P. falciparum cDNA phage library Identification of PfEBL-1 that bind
glycophorin B on the surface of
erythrocytes
Li et al., 2012
Purified human
erythrocyte protein 4.1
Plasmodium cDNA phage library Identification of EBA-175, EBL-1 and a
Ser/Thr kinase as ligands for protein 4.1
Lauterbach et al., 2003
AMA-1 Random peptides Identification of peptides that bind
AMA-1 and inhibit parasite invasion of
erythrocytes; structure determination of
AMA-1 epitope targets of inhibitory
human antibodies
Nair et al., 2002; Keizer et al.,
2003
Mouse antibodies Identification of four antibodies specific
for Plasmodium AMA-1
Sabo et al., 2007
Anti-AMA-1 and
anti-rhoptry mAbs
Random peptides Identification and structural elucidation of
AMA-1 mimics. Antibodies to
mimotopes that inhibit erythrocyte
invasion by Plasmodium
Narum et al., 2006
CSP Phage library of CSP peptides Induction of a strong and specific
immune response. Structure
determination of a CSP epitope
Greenwood et al., 1991;
Monette et al., 2001
MSP Human and mouse antibodies Isolation of three antibodies against
MSP-3 and MSP-1 that inhibit parasite
growth
Sowa et al., 2001; Lundquist
et al., 2006; Cheng et al., 2007
Random peptides Identification of MSP mimotopes Demangel et al., 1996
SERA5 enzyme Random peptides Identification of a peptide that binds the
catalytic domain of the enzyme and
affects intraerythrocytic development
Fairlie et al., 2008
Pfs48/45 protein Human antibodies from
malaria-immune patients
Isolation of a scFV that reacts with
sexual stages of P. falciparum and
Pfs48/45 protein
Roeffen et al., 2001
Duffy binding protein
(DBP)
Human antibodies from
malaria-immune patients
Identification of three scFV that binds
(DBP) inhibiting adhesion of RBCs
Kim et al., 2007
et al., 2009). Single-chain variable fragment (scFv) phagemid
library has also being used to identify for specific scFvs that bind
to C. parvum. As a result, panning against the surface protein P23,
revealed two scFv sequences that were able to detect both native C.
parvum proteins and recombinant P23. Importantly, the selected
fragments showed no cross-reactivity with E. coli, S. pyogenes,
L. monocytogenes, B. cereus, G. lamblia (cysts or trophozoites),
or with S16, another dominant surface antigen on C. parvum
sporozoites (Boulter-Bitzer et al., 2009).
Eimeria
Infection of chicken with Eimeria, the causative agents of coccid-
iosis, is a serious problem for the poultry industry being respon-
sible for varying degrees of morbidity and mortality between
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Table 2 | Summary of phage display applications in T. gondii research.
Target Library Result References
Sera of T. gondii-infected
individuals
T. gondii cDNA phage library Identification of epitopes of the T. gondii
antigens
Beghetto et al., 2003; Di Cristina
et al., 2004
Sera of T. gondii-infected
pregnant women
T. gondii cDNA phage library Identification of an epitope GRA1 protein Beghetto et al., 2001
Anti-T. gondii mAbs T. gondii cDNA phage library Identification of an epitope of GRA3
located in the dense granules of T. gondii
tachyzoites
Robben et al., 2002
Random peptides Identification of a linear epitope within
SAG2A that is expressed in T. gondii
tachyzoite surface
Cunha-Junior et al., 2010
TgMIC2 Mouse antibodies from T. gondii
immune animals
Identification of scFV antibodies that
recognize TgMIC2
Hoe et al., 2005
Table 3 | Summary of phage display applications in C. parvum research.
Target Library Result References
C. parvum glycoproteins C. parvum-specific polyclonal
antibody library
Identification of antibodies that recognize
C. parvum glycoprotein and
oocyst/sporozoite preparations
Chen et al., 2003
C. parvum oocysts Human semi-synthetic phage
display antibody libraries
Isolation of scFv antibodies that block
infection of HCT-8 cells by C. parvum
Pokorny et al., 2008
Sporozoite surface
antigen S16 and P23
Human semi-synthetic phage
display antibody libraries
Isolation and identification of scFV
antibodies that bind to C. parvum
Boulter-Bitzer et al., 2009, 2010
Intestinal epithelial cells
(IECs)
C. parvum cDNA phage library Identification of a surface adherence
protein (CP12) from sporozoites
Yao et al., 2007
infected birds. Eimeria parasites invade and develop within the
avian IECs causing tissue damage that results in blood loss, dehy-
dration, nutrient malabsorption, and increased susceptibility to
other opportunistic pathogens. The parasite is acquired by the
ingestion of sporulated oocysts that release sporocysts, which in
turn release invasive sporozoites. These invade the avian intestinal
tract and once inside the host cells they round up as a tropho-
zoite. At the end of the cycle, Eimeria parasites leave the cells as
merozoites, which further infect fresh host cells. Control of avian
coccidia is being a main challenge in veterinary science and, con-
sistently, studies using phage display are directed toward this end.
This is reflected on a work where a phage display library was used
to screen for peptides with in vitro activity against E. acervulina
and E. tenella sporozoites using living purified E. acervulina
sporozoites as targets. The selected peptide (PW2) disrupted the
sporozoite pellicle, similarly to most natural antimicrobial pep-
tides and showed a very low lytic effect on mammalian and avian
cells, suggesting a potential use as a drug against avian coccidio-
sis. A variation on this theme is the panning of antibody libraries
against different development of Eimeria parasites. Heavy chain
(VH) and light chain (VL) antibody libraries against E. acervulina
merozoites (Zhao et al., 2010) and scFV antibody libraries against
E. tenella sporozoites (Abi-Ghanem et al., 2008) were used aiming
at the development of new tools for diagnosis and therapy against
coccidiosis. Selected examples of these applications are listed in
Table 4.
STUDIES ON KINETOPLASTIDAE–HOST INTERACTIONS USING PHAGE
DISPLAY
The Kinetoplastidae are a class of unicellular and flagellated
protozoan parasites responsible for serious diseases in humans
and animals. Members of this class include all species of
Trypanosomatidae, as Leishmania and Trypanosoma (T. cruzi and
T. brucei).
Trypanosoma cruzi
T. cruzi, the American trypanosome, is an obligatory intracellular
parasite that circulates between an invertebrate host (Triatomine
insects) and a vertebrate host. In the latter, development ofT. cruzi
parasite begins with an intracellular amastigote form that repro-
duce within different cell types by binary fission. After successive
rounds of replication, amastigotes differentiate into the infec-
tive and non-replicative trypomastigotes, which are released from
the infected cell. The surface of the infective trypomastigotes
of T. cruzi is covered by glycoproteins important for the adhe-
sion and/or internalization of the parasite to host cells and one
Frontiers in Immunology | Microbial Immunology January 2013 | Volume 3 | Article 419 | 6
Tonelli et al. Phage display and aptamers in protozoan parasites
Table 4 | Summary of phage display applications in Eimeria research.
Target Library Result References
Eimeria sporozoites/live Random peptides Identification of PW2 peptide with
activity against E. acervulina and
E. tenella sporozoites
da Silva et al., 2002
E. tenella sporo-
zoites/cryopreserved
Chicken scFV antibodies from
E. tenella immune birds
Isolation of an scFV antibody that binds
specifically to E. tenella sporozoites
Abi-Ghanem et al., 2008
Cryopreserved E.
acervulina merozoites
Chicken scFV antibodies from
E. tenella immune birds
Identification of antibody fragments with
high specificity and binding capacity for
soluble antigens and intact fixed
merozoites
Zhao et al., 2010
Anti-GAM56 protein E. tenella cDNA phage display Identification of EtGAM22 expressed
predominantly at the gametocyte stage
Krucken et al., 2008
example is the superfamily of GPI-anchored glycoproteins named
gp85/trans-sialidase. The majority of this superfamily members
have at the subterminal carboxyl side the motif VTVxNVFLYNR
(known as FLY domain) involved in host cell binding (Magdesian
et al., 2001). It has long been known that heart and gastroin-
testinal tract cells are important targets for T. cruzi infection
playing significant roles in pathogenesis and maintenance of par-
asitic reservoirs. The nature of this tropism is not well known
and understanding the determinants of this feature can con-
tribute to T. cruzi control and drug development. Interestingly,
randompeptide libraries of bacteriophages injected intravenously
pointed out to differences in the blood vessels of different organs
(Pasqualini and Ruoslahti, 1996; Arap et al., 2002), raising the
notion that the vascular bed expressed specific molecular mark-
ers or ZIP codes allowing the delivery of cells or molecules
to designated targets (Rajotte et al., 1998). Infectious agents
could also exploit these differences in the expression of vascular
addresses to gain access to target tissues/organs were they could
develop. A combination of immortalized endothelial cells (ECs)
and phage display methodologies were employed to investigate
whether the FLY domain could interact with the blood vessel and
contribute to T. cruzi tissue homing. Initially, filamentous bacte-
riophages were genetically engineered to display the FLY peptide
on the pIII minor coat protein (FLY phage). Using that strategy,
it was shown that the FLY phage, but not the control phages,
binds strongly to ECs derived from the heart and the bladder,
two organs in which parasites can be found following infec-
tion (Tonelli et al., 2010). Furthermore, hybrid phages injected
intravenously into mice demonstrated that FLY binds to the vas-
culature of different organs but is enriched in the vasculature of
the heart, bladder, and esophagus in agreement with the cell bind-
ing in vitro assay (Tonelli et al., 2010). These results indicated
that T. cruzi tropism at the molecular level could be explained,
at least in part, through the interaction of the FLY motif with
receptors present in the vascular bed of different organs. Indeed,
this was the first experimental demonstration on how the use
of phage display technologies can help to elucidate the mech-
anisms by which T. cruzi interacts with blood vessel receptors
in vivo.
A phage display library was employed to help the identification
of B-cell epitopes on the T. cruzi trans-sialidase (TcTS) (Pitcovsky
et al., 2001). Trans-sialidase, a GPI-anchored glycoprotein, is shed
by T. cruzi, being detected in the blood of infected patients dur-
ing the acute phase of the disease. This enzyme is responsible for
the direct transfer of sialyl residues from the host cells to accep-
tor proteins on the surface of infective trypomastigotes. Both,
phage display technology and affinity-purified TcTS antibodies
from T. cruzi infected rabbits were instrumental to isolate sev-
eral B-cell epitopes located within or near the catalytic N-terminal
domain of TS showing reactivity with sera obtained from T. cruzi
infections. More importantly, some of the selected peptides
were exposed on the surface of the TcTS probably explaining
their strong antigenicity (Pitcovsky et al., 2001). Using the same
approach the trypomastigote-restricted shed acute-phase anti-
gen (SAPA) from T. cruzi was also mapped. The SAPA antigen
is a 12-amino acid repetitive unit displayed in tandem on the
carboxyl-terminus of the TcTS and it is the immunodominant
antigen during T. cruzi infections. Screening of a phage display
library of random peptides against anti-SAPA mAbs and puri-
fied immunoglobulin G from SAPA-immunized rabbits resulted
in the identification of multiple linear overlapping B-cell epitopes
within the repeated unit of SAPA (Alvarez et al., 2001). These data
shed light on the molecular structure of the SAPA antigen and
on how repetitive antigens are recognized by the immune system.
Table 5 summarizes work on trypanosomes.
African trypanosomes
Sleeping sickness or human African trypanosomiasis (HAT) is
caused by subspecies of the protozoan parasite T. brucei (T. b.
gambiense in West and Central Africa). T. brucei is transmitted
by tsetse flies of the genus Glossina and once inside the verte-
brate it escapes from the host immune system by continuously
replacing the major parasite antigens on the plasma membrane,
the variant surface glycoproteins or VSG. This successful tactic
of the parasite to avoid the defense of the host turned T. brucei
detection laborious and insensitive, limiting the identification of
possible infected individuals. This observation led investigators to
search for new ways of accurately identifying HAT-specific VSG
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Table 5 | Summary of phage display applications in research with T. cruzi and T. brucei.
Target Library Result References
T. cruzi
Mouse vascular bed Hybrid phage displaying the FLY
domain
FLY interacts with the endothelium in an
organ-dependent manner with a preference for
the heart vasculature
Tonelli et al., 2010
TcTS-specific antibodies
and anti-SAPA mAbs
Random peptides Identification of B-cell epitopes located on TcTS
and the SAPA antigen
Pitcovsky et al., 2001
T.b. gambiense
Sera of T.b.
gambiense-infected
mouse and humans
Random peptides Identification of epitopes of the T.b. gambiense
VSG antigens
Van Nieuwenhove et al., 2011,
2012
epitopes (mimotopes) possibly recognized by the host immune
system. Two studies illustrate well this idea (Van Nieuwenhove
et al., 2011, 2012). In one study, two phage display libraries of
random peptides (12-mer and cyclic 7-mer) were screened with
mouse MAbs against the two predominant T.b. gambiense VSGs
proteins (LiTat 1.3 and LiTat 1.5). The result was the isolation of
several peptides that mimicked epitopes on the native trypanoso-
mal VSGs LiTat 1.5 and LiTat 1.3 (Van Nieuwenhove et al., 2011).
Some of the selected peptides were then confirmed as mimotopes
for the parasite VSGs since they were able to inhibit the bind-
ing of their homologous monoclonal to the corresponding VSG
(Van Nieuwenhove et al., 2011). In a second work focused on
the screening of phage display libraries against polyclonal anti-
bodies from sleeping sickness patients sera, two mimotopes of
VSG have been found to react positively in indirect ELISA with
a panel of 102 HAT positive and 102 endemic negative sera (Van
Nieuwenhove et al., 2012). Both studies illustrate how the phage
display platform can help to isolate epitopes against infectious
agents with potential use in diagnostics. Table 5 summarizes work
on trypanosomes.
APTAMERS
The SELEX technology is an oligonucleotide-based combinato-
rial library method to select high affinity ligands (aptamers, from
aptus, “to fit”) to almost any target molecule, including peptides,
or cells (Cell-SELEX) (Ulrich and Wrenger, 2009; Ahmadvand
et al., 2011; Gold et al., 2012). It is based on a stretch of single-
stranded nucleic acid, which can be RNA or ssDNA. These are
chemically synthesized to have a segment usually from 8 to 40
nucleotides randomly bound. These sequences tend to assume
different conformations, due to the formation of: (1) hairpins,
which are helical double stranded structures due to comple-
mentarity of nucleotides, like in the classical t-RNA secondary
structures; (2) G-tetrads, which is an association of four gua-
nine bases through hydrogen bonding forming a planar squared
structure; when these tetrads pile on top of each other and are
stabilized by a cation, a G-quadruplex is formed (Johnson et al.,
2008); (3) bulges, which occur when a duplex helix is inter-
rupted by a single stranded stretch of nucleotides in only one
strand; usually this may form a weak point leading to bending
of the helical axis (Lilley, 1995); and (4) pseudo-knots formed
by the intercalation of stem-loop structures (Staple and Butcher,
2005). These different topologies with varying loop configura-
tions change the whole geometry of the nucleic acid molecules
determining the formation of secondary and tertiary structures
that provide a large diversity for the recognition of specific
molecules and receptors on cell surfaces. Thus, aptamers are
bioactive target-specific compounds that can be used to iden-
tify and modulate the activity of surface targets embedded in
the membrane of cells relevant for human disease, either for
diagnostic or therapeutic purposes.
The SELEX technique uses reiterative in vitro selection of com-
binatorial RNA or DNA pools against a target molecule for the
identification of aptamers that are high-affinity oligonucleotide
ligands. Aptamers isolated by such iterative method recognize
their targets with binding specificities and affinities compara-
ble to those of monoclonal antibodies, with the advantage to
be easily chemically modified as to avoid nuclease attack. Thus,
due to the fact that aptamers may recognize epitopes exclusively
expressed by the target cell, they may be employed even to recog-
nize different physiological states of a given cell, being capable, for
example, to distinguish between protein isoforms and different
conformations of the same protein.
When RNA aptamers are desired, the RNA pool used in
the selections is transcribed from a pool of synthetic DNA
templates (Figure 1). Each of these may contain, for exam-
ple, 108 nucleotides with a 40 nucleotide randomized region
flanked on both sides by constant sequences. The 5′ nucleotide
sequence upstream the randomized region is a promoter for
T7 phage RNA polymerase (Famulok et al., 2000). Two-fluoro-
pyrimidine triphosphates can be used as substrates for RNA poly-
merase to provide stability of the transcribed products against
nuclease attack (Ito et al., 1998). Such synthetic DNA pool
is transcribed using T7 RNA polymerase in the presence of
2′-OH-ATP and GTP and 2′-F-CTP and UTP (Ruckman et al.,
1998).
The obtained RNA molecules can now be incubated with any
target, a protozoon for example, to enable RNA:cell surface bind-
ing to occur (cell-SELEX). The cell:RNA complexes are separated
from free RNAmolecules and the bound RNA is eluted by compe-
tition with the desired ligand. The liberated RNA is then isolated,
reverse transcribed, and amplified by standard PCR procedures
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(Figure 1). This SELEX procedure will be repeated for 9–12 selec-
tion rounds until no further increase in binding affinity can be
measured (Irvine et al., 1991). To obtain more specificity, one or
more of the iterative rounds can be done against a cell close to
the one of interest in order to select out aptamers that are shared
by different differentiation forms (negative selection). For exam-
ple, one may use merozoites of P. falciparum to eliminate RNAs
bound to targets that are shared with sporozoites. The sequence
described above follows the same logic when aptamers carrying
ssDNA sequences are used instead of RNA (Ulrich and Wrenger,
2009).
Targets can be isolated either by aptamer immobilization on
magnetic beads or by affinity chromatography. Also, receptors on
cells can be photocrosslinked with their RNA/DNA aptamers to
facilitate target protein isolation. Finally, aptamers can be labeled
with fluorescent labels to facilitate separations of cells by FACS
(Ulrich and Wrenger, 2009).
SOMAmers (Slow Off-rate Modified Aptamers), a term intro-
duced by Gold et al. (2010), are short, single stranded deoxyri-
bonucleotides, bearing dU-modified residues. Like aptamers, they
can be selected against any target molecule. The method for
selecting SOMAmers with low dissociation rates (t1/2 > 30min)
and elimination of non-specific binding (employing an excess
of a polyanionic competitor, for example) were developed and
reported to show high success rates on selection when compared
to the traditional aptamers: using four modified nucleotides
(5-benzylaminocarbonyl-dU, 5-naphthylmethylaminocarbonyl-
dU, 5-tryptaminocarbonyl-dU, and 5-isobutylaminocarbonyl-
dU) into the SELEX experiments, the overall success rate
increased by ∼84% in approximately 1200 proteins analyzed
(Gold et al., 2012). The initial modifications of the pyrimidines
have been expanded and the method applied to solve large
scale analysis of biological samples, such as finding biomark-
ers for drug development and for diagnosis (Gold et al., 2012).
As reported, more than 800 SOMAmers were already selected,
meaning that 800 human proteins can be detected simultane-
ously in a high throughput assay using 15μl of sample (Gold
et al., 2012). According to Gold and collaborators, the new
aptamers are so important for technological application that
they call them SOMAmers, to distinguish them from the prior
literature.
Although aptamers are most frequently defined as DNA or
RNA molecules, peptide aptamers are important members of
the group. Selection of peptide aptamers depends mainly from
a random peptide library (often thioredoxin A is the scaffold pro-
tein) and on yeast two-hybridization system (Liu et al., 2013).
The importance of the peptide aptamers in the parasitology
can be exemplified by a recent report showing the inhibition
of DNA damage repair and survival in T. brucei by a peptide
aptamer mimicking RAD51-binding domain of BRCA2 (Hall
et al., 2011). BRCA2, a multifunctional scaffolding protein, is
implicated in different cellular processes, including its interaction
with DNA recombinase proteins of the RAD51 family. BRCA2
from T. brucei, also essential for Variant Surface Proteins switch-
ing, interacts with RAD51 through BRC motifs, a 44 amino
acid long repeat unit. Interestingly, since T. cruzi and Leishmania
have similar machineries, and T. brucei BRCA2 is distinct from
mammalian BRCA2, the authors predict the development of
an optimized peptide aptamer that will work against the tri
trypanosomatids.
DNA and RNA-aptamers applied to studies on trypanoso-
matids and apicomplexa are discussed below.
THE USE OF APTAMERS IN THE STUDY OF PARASITIC INFECTIONS
As pointed out, the number of articles in the literature describ-
ing the use of aptamers is scarce: while a database search of
PubMed reveals almost 3000 publications making use of the term
“aptamers” only less than three dozen publications reported the
use of aptamers to study pathogens. Of these, most were related to
studies on African and American trypanosomes, Plasmodium and
Leishmania, which will herein be focused and are summarized in
Table 6 (Goringer, 2012).
STUDIES ON KINETOPLASTIDAE USING APTAMERS
Trypanosoma cruzi
The interaction of T. cruzi trypomastigotes with extracellular
matrix (ECM) components is vital for the establishment of infec-
tion in the vertebrate host (Alves and Colli, 2007). Recognizing
the importance of this interaction to the success of T. cruzi
infection, the SELEX approach was used to evolve aptamers
with binding affinities for ECM molecules such as laminin,
fibronectin, thrombospondin, and heparan sulfate. Therefore,
serum stable RNA aptamers that bind to parasite receptors
to ECM were obtained after eight selection rounds, each one
involving the incubation of trypomastigotes with a RNA pool
(∼2 × 1013 molecules, consisting of 108 nucleotides with 40-
nucleotide randomized region), followed by displacement of the
bound molecules with ECM components. One or more itera-
tive rounds were made against T. cruzi epimastigotes to eliminate
aptamers that bind to targets common to both differentiation
forms. Ninety-six clones were sequenced and four classes of
RNA aptamers were established based on structural analysis. The
selected RNA aptamers bind in the nanomolar range to the para-
site receptors for heparan sulfate (40 nM), fibronectin (140 nM),
laminin (200 nM), and thrombospondin (400 nM) (Ulrich et al.,
2002). Importantly, all four selected aptamers, inhibited T. cruzi
invasion of epithelial cultured cells by 50–70%, with the best inhi-
bition obtained with the laminin class of aptamers. Although
these aptamers confirmed the adhesion of T. cruzi to the ECM,
the invasion blockage was incomplete, even when all the four
classes of aptamers were added together. The existence of other
molecules involved in the invasion of host cells by the para-
site, an already known complex event (Alves and Colli, 2007)
and the binding affinity of the aptamers in the nanomolar range
may explain the results. In addition, the possible clearance of
the aptamers from the surface of the parasite by shedding has
to be considered. Remarkably, GPI-anchored surface glycopro-
teins from the Tc85 group that bind to laminin (Giordano
et al., 1999) are shed as membrane vesicles (Torrecilhas et al.,
2012), with a 3.5 h half-life (Gonçalves et al., 1991). The data
demonstrate that the SELEX technique can be employed to iso-
late aptamers against parasite targets, which may be useful in
inhibiting parasite invasion. However, aptamers that recognize
other molecules may be included, as for example molecules that
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Table 6 | Summary of the applications of aptamers on protozoan parasite research.
Target Library Result References
T. cruzi
T. cruzi ligands for ECM
components
2′-F-dU/dc-RNA 50–70% inhibition of epithelial cell invasion by T. cruzi. The
best inhibition was obtained with aptamers targeted to the
laminin receptor
Ulrich et al., 2002
T. cruzi 2′-F-dU/dc-RNA Development of an aptamer-based concentration method
for the detection of T. cruzi in blood
Nagarkatti et al., 2012
T. brucei
T. brucei bloodstream
forms
2′-F-dU/dC-RNA Identification of an aptamer family that binds to a flagellar
pocket component. Aptamer internalization through the
lysosome pathway
Homann and Goringer, 1999
Preparation of VSG
variants
2′-F-dU/dC-RNA Isolation of aptamers with affinity for many VSGs variants.
Binding to live parasites
Lorger et al., 2003
T. brucei 2′-NH2-dU/dC-RNA Binding to the flagellar attachment zone Homann et al., 2006
Leishmania
L. tarentolae isolated
mitochondria
Reporter RNA RNA-aptamer base methodology for measuring RNA
editing activity in the low femtomole range
Liang and Connell, 2009
L. tropica RNA Identification of signals for RNA import into the
mitochondria
Bhattacharyya et al., 2002
L. infantum DNA Binding to the surface protein KMP-11 Berberich et al., 1997
L. infantum DNA Binding to histones (H2A and H3) Ramos et al., 2007, 2010
Plasmodium
P. falciparum PfEMP1 2′-F-dU/dc-RNA Binding to PfEMP1 exposed at the surface of
infected-erythrocytes. Rosette disruption by aptamers
Ghosh et al., 2001, 2002
P. falciparum parasitized
erythrocyte
DNA Inhibition of hemozoin formation and parasite growth by
heme binding aptamers
Niles et al., 2009
are also shed and are known to enhance parasite invasion, as
gp85/transialidase (Tonelli et al., 2011; Rubin and Schenkman,
2012) to improve the possibility of finding therapeutic approaches
through aptamers.
Due to migration, approximately 390,000 humans infected
with T. cruzi were detected in the United States (∼75% of the
cases), Europe, western Pacific, Canada, Japan and Australia
(Coura and Vinas, 2010). In this scenario, since blood transfusion
is one way of T. cruzi transmission, methods with high sensi-
tivity and specificity for the parasite detection are crucial. Most
of the methodologies developed are based on antibodies (ELISA
assays) or live parasites (PCR). However, false negative results can
be obtained in both cases, due to low amount of antibodies (as
in the initial phase of the disease) or to few circulating parasites
(as in the asymptomatic cases or chronic phase of the disease).
Moreover, detection of antibodies is not a good parameter of
cure for Chagas’ disease, since the antibodies persist in circula-
tion for a certain period of time, even after the parasite killing, in
addition to cross-reactivity problems among the trypanosomatids
parasites.
Looking for the improvement of a diagnostic method based
on live parasites, an aptamer-based concentration of T. cruzi
in blood was recently reported (Nagarkatti et al., 2012). Using
SELEX strategy, serum stable RNA aptamers that bound to
live trypomastigotes with high affinity (8–25 nM ranges) were
selected. One aptamer (Apt68) bound specifically to trypomastig-
otes, but not to epimastigotes or other related trypanosomatids
(L. donovani and T. brucei) with high affinity (Kd ∼7.6 nM). It
was also shown that Apt68 immobilized on a solid phase was
able to capture and aggregate trypomastigotes from different
strains. Moreover, using a magnet, trypomastigotes aggregated
to Apt68-coated paramagnetic beads could be purified from the
blood and detected by real-time PCR assay, even at concentra-
tions as lower as five trypomastigotes/15 ml. The purification
step of the parasite prior to DNA extraction presents technical
advantages in relation to the direct extraction from the whole
blood, in addition to the volume reduction of the blood sample
employed.
African trypanosomes
Aptamers against the infective bloodstream forms of T. brucei
were selected by incubating the parasite with a RNA library (2 ×
1015 unique sequences) (Homann and Goringer, 1999). After
12 cycles of selection, 53 clones were sequenced, resulting in
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the identification of three structural families of aptamers, one
of which being further characterized. The aptamer 2–16 RNA
was specific for the bloodstream stage, since it did not react
with the insect stage of the parasite, and bound with high affin-
ity (Kd ∼60 nM) to a 42 kDa protein located within the flagellar
pocket of the parasite. Moreover, the aptamer also bound to
two other T. brucei strains. In order to be employed in vivo, the
aptamer 2–16 was chemically modified, retaining the same prop-
erties as the original unmodified molecule, as well as a good
stability in vivo (half-life in serum of 3.4 days) (Adler et al., 2008).
Aptamers that recognized the flagellar attachment zone with high
affinity (Kd = 70 ± 15 nM) were also selected against the blood-
stream stage of T. brucei (Homann et al., 2006). The half-life was
determined as more than 30 h, showing a good stability in serum,
an important characteristic for using the aptamer as a therapeutic
device.
As pointed out before, bloodstream forms of T. brucei evade
the host immune system by switching temporarily the single
VSG that covers the surface of the parasites (antigenic varia-
tion). Despite the low identity of the amino acid composition
among the VSG repertoire, the presence of similar tertiary struc-
tures, hidden from the antibody attack, was the rationale for
selecting aptamers against the conserved structures (Lorger et al.,
2003). For the selection, a homogeneous preparation of VSG
(variant 117) was incubated with a combinatorial library of
2 × 1014 unique RNA sequences. After three rounds of selec-
tion, the aptamers were incubated with live parasites expressing
the same VSG variant to remove RNAs that did not recognize
the native membrane-bound protein. Finally, the same scheme
was employed using a different VSG (variant 221) and para-
sites expressing VSG 221. As a result, RNA aptamers common to
both VSG variants were obtained. After round nine, 60 individual
clones were sequenced and placed into three groups, accord-
ing to sequence motifs (76% in group I) in addition to orphan
RNAs (6%). Aptamers from the three groups bound to the VSGs
in the nanomolar or subnanomolar concentration range (Kd =
0.16 ± 0.02 nM for clone nine), recognized other VSG variants
from T. brucei, as well as from T. congolense and showed good
serum stability (15 h). The biotin-labeled aptamers/fluorescent-
conjugated streptavidin methodology demonstrated binding of
the three groups of aptamers to the whole surface of live T. bru-
cei expressing different VSG variants. Also, the biotin-labeled
aptamers bound to the surface of the trypanosome and detected
by anti-biotin antibodies could be used to drive immunoglobulins
to the surface of the parasite.
Leishmania tarentolae
RNA editing, a molecular process found in trypanosomatids, reg-
ulates gene expression in their sole mitochondrion. It consists in
the insertion and deletion of uridylates in mitochondrial mRNAs
guided by small RNAs. The process occurs in a multi-protein
complex (editosome), with endonuclease, uridylate transferase,
uridylate-specific 3′exoribonuclease and RNA ligase being the
four major enzymes involved. Incorrect function of editosome
leads to parasite death, as shown for T. brucei (Schnaufer et al.,
2001; Tarun et al., 2008). Although editosomes are common to
other Kinetoplastidae parasites, their protein content may not be
identical, as shown for example for two new proteins from T.
brucei (KREPB9 and KREPB10), which are associated with the
editing activity of the endonuclease. Both proteins are absent
in Leishmania and KREP 10 is absent in T. vivax (Lerch et al.,
2012). RNA editing is an attractive target for chemotherapy, as
pointed out by the abundant literature in the field (Niemann
et al., 2011).
The identification and exact function of each component of
the editosome is then essential and sensitive assays to detect
editing activity have been proposed. Among them, a RNA
aptamer-based methodology was developed using a mitochon-
drial population from L. tarentolae as an initial source (Liang and
Connell, 2009). The method detects the editing activity by an
electrochemiluminescent signal generated by an editing respon-
sive conformational change within a ruthenium labeled RNA
reporter. It is claimed that the method detects the edited product
in the femtomole range and can be performed in small vol-
umes (12μl in 384-well microtiter plate) making it suitable for
high-throughput screening.
Leishmania tropica
The SELEX method was employed to identify the import sig-
nals of cytoplasmatic RNA by mitochondrial receptors. After four
rounds of SELEX, the pool of aptamers was further selected by
its capacity to be efficiently imported by the mitochondria. Four
aptamers were studied in more detail and classified in two types
by their efficiency in crossing the inner mitochondrial membrane
(type I: A and D arm homologues; type II–V-T homologues, a
new putative import signal). Furthermore, considering the effi-
ciencies of aptamers transport into the mitochondria, cooperative
and antagonistic interactions among them have been reported,
which may be important for the regulation of RNA import, as
suggested by the authors (Bhattacharyya et al., 2002).
Leishmania infantum
KMP-11 is a surface protein associated with Kinetoplastidae par-
asites cytoskeleton, such as T. cruzi, T. brucei, L. donovani, and L.
infantum and differentially expressed during the parasite life cycle
(Tolson et al., 1994; Stebeck et al., 1995; Berberich et al., 1997). A
high antibody response against KMP-11 during natural infection
of L. infantum was reported (Berberich et al., 1997), as well as the
stimulation of T-lymphocytes proliferation (Tolson et al., 1994).
These characteristics raised the possibility that KMP-11may be an
important tool against infection by Leishmania. DNA aptamers
were then selected against KMP-11 protein and after a 10-round
cycle, aptamers that specifically recognized KMP-11 were selected
(Moreno et al., 2003) and are awaiting further characterization.
Although highly conserved among different eukaryotes, his-
tones from trypanosomatids show sequence divergences in the
amino- and carboxy-terminal domains. High affinity and spe-
cific DNA aptamers were then selected against L. infantum H2A
(Ramos et al., 2007) and H3 (Ramos et al., 2010).
STUDIES ON APICOMPLEXA USING APTAMERS
Plasmodium
During erythrocyte infection P. falciparum secretes proteins to
the surface of the RBCs associated with cytoadherence of the
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infected erythrocytes to the endothelium of blood vessels or to
other non-infected erythrocytes, monocytes, and platelets, lead-
ing to rosette formation, a phenotype associated with virulence.
The presence of infected erythrocytes in microvessels associated
with host responses to the sequestered erythrocytes are centrally
involved in the disease pathology. Moreover, 48 cycles of inva-
sion and development inside erythrocytes are made possible by
the cytoadherence mechanism while the parasite circulates in the
bloodstream. Cytoadherence and rosetting are associated with
PfEMP-1 protein (parasite-derived erythrocyte membrane pro-
tein) that is exposed on the erythrocyte surface and binds to a
different number of human cell receptors, such as heparan and
chondroitin sulfates, ICAM-1, CD36 (Fairhurst et al., 2012). A
good strategy to minimize malaria mislays is to raise ligands for
a more conserved region of PfRMP-1 responsible for adhesion,
such as the DBL1α, a rosette forming domain. Using a combina-
torial library of 5 × 1014 unique RNA sequences and eight rounds
of selection against DBL1α, 85 clones were sequenced and ana-
lyzed (Barfod et al., 2009). Two aptamers that bind to PfEMP1 on
the surface of infected erythrocytes decrease the rosette formation
by 35% at 33 nM concentration and by 100% at 38 nM, pointing
out to their potential use as candidates for severe malaria therapy
(Barfod et al., 2009).
Hemoglobin digestion in Plasmodium occurs in acidic vac-
uoles, as a result of an extensive uptake of erythrocytic cytoplasm
by mid ring and mid trophozoite stages, both early intraerythro-
cytic stages of the parasite (Bakar et al., 2010). The digestion
results in the production of globin, a source of amino acids,
and free heme molecules (Fe2+-protoporphyrin IX), which are
toxic to the parasite. The oxidation of the heme group results in
Fe3+-protoporphyrin IX, which precipitates inside the vacuoles as
crystals known as hemozoin (malaria pigment) (Weissbuch and
Leiserowitz, 2008).
Anti-malarial drugs extensively used in clinic, as chloroquine
or artemisinin act during the degradation of hemoglobin and
subsequent hemozoin formation (Weissbuch and Leiserowitz,
2008). Artemisinin, for instance, delays hemoglobin uptake and
a product of the hemoglobin hydrolysis potentiates its activity
(Klonis et al., 2011). The pathway for hemoglobin degradation
is then a suitable target for the development of new drugs and
aptamers are good candidates. Heme binding DNA aptamers pre-
viously selected in vitro by SELEX carried out at pH 7–8 (Li et al.,
1996; Okazawa et al., 2000) were employed to interfere with the
heme-detoxification in P. falciparum. The selected aptamers bind
equally to heme at acidic pH, the environmental condition of
the vacuolar structures responsible for hemoglobin digestion, and
inhibit hemozoin formation in vitro. Two of the heme-binding
aptamers were used to verify their effect on parasite growth. The
erythrocytes were first loaded with the aptamers using hypo-
tonic lysis and resealing conditions, reaching the level of 65–85%
of aptamers-loaded cells. Parasite growth in the preloaded-heme
binding aptamers cells was significantly reduced after 72 h in
culture, when compared to the controls (Niles et al., 2009).
The aptamers, as suggested, may be useful tools for elucida-
tion and manipulation of pathways important for the parasite
survival.
CONCLUDING REMARKS
Phage display and SELEX are powerful methodologies to be
employed in a variety of systems to approach different questions,
from the understanding of cell biology to biotechnology. Both
techniques share important characteristics, such as the possibil-
ity to use large oligonucleotide-based or phage display peptide
libraries to screen almost any target, including the whole liv-
ing cell or animal models. Chemical modification of aptamers
and peptides poses an additional advantage over the phage dis-
play as it allows more stability in blood for therapeutic use.
Particularly, aptamers seem to lack immunogenicity, which, asso-
ciated with high affinity and specificity to their targets may easily
substitute antibodies for therapeutic purposes, although a fast
clearance of the aptamers have been shown in the literature.
Besides its use directly to neutralize its target, aptamers also
can be used as agents to deliver nanoparticles loaded with spe-
cific therapeutic drugs or iRNA (Liu et al., 2013). Blood-living
or transiently blood-living parasites, as T. brucei, T. cruzi, or
Plasmodium are good targets for this kind of approach. The same
rational can be easily applied for any parasite-induced modifi-
cation of the host cell surface, such as the knob-like structures
in Plasmodium-infected erythrocytes. However, its application
will be much more complex when parasites that live into the
host cell cytoplasm (such as T. cruzi) or inside vacuoles (such
as Leishmania) are considered. Indeed, as the advantages of tar-
get therapy become more apparent, the use of phage display
and aptamers to retrieve for disease-related antigens are receiving
increased attention. Additionally, aptamers-carrying iRNA may
have diverse applications, as helping the understanding of the
role of the innumerous proteins involved in the parasite–host cell
interaction or inhibiting the expression of proteins from parasites,
which possess the iRNA machinery. Besides its use on parasite–
host interactions, phage display technology may be engineered
for a particular functional activity as, for example, to display
human antibodies with high affinity and specificity for particu-
lar antigens in disease. In humans, phage antibody libraries made
from donors who naturally mount an immune response (with
viral infections, bearing tumors, or with autoimmune disease) is
being used not only to investigate the humoral response in dis-
ease but also with clinical purposes (Hoogenboom and Chames,
2000). These would be an interesting approach as therapy against
parasitic diseases.
The application of aptamers for molecular imaging is being
used in clinics for the evaluation of several diseases (Cibiel et al.,
2012) with the great advantage of not being an invasive method-
ology and may be helpfully applied also in parasitology. An
exciting use of the technique for cell biology is the imaging of
cellular metabolites with RNA-based sensors recently described,
where the intracellular levels of ADP and S-adenosylmethionine
were measured (Paige et al., 2012). Since RNA aptamers to
any molecule can be rapidly selected, a rapid expansion of the
methodology to other small molecules is envisaged.
As shown by the low number of reports in the literature, it is
surprising that these methodologies were not, as yet, employed
more often in the study of the complex phenomenon of host–
parasite interaction, with the aim to develop much needed
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diagnostic and therapeutic tools to combat infections caused
by protozoan parasites. Notwithstanding, considering the con-
stant and fast improvement of both technologies and their large
applicability to different biological problems, it is expected that
phage display and SELEX will make, in a near future, significant
contributions to the field of protozoan-borne diseases.
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